Tag Archives: mergers & acquisitions

The Cost of Pharma Divorce

Final: THE COST OF PHARMA DIVORCE Corporate spin-offs are on the rise across the pharmaceutical sector, but at what cost to shareholders? Brian McGilligan, AVP, Life Sciences Program Management Consulting Lead at Cognizant argues that in haste to obtain decree absolute, demerging businesses could be threatening their long term viability. Demergers are in fashion again. […]
Posted in Deals, Global, Guest Blog | Also tagged , | 1 Comment
  • Categories

  • Meta